• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Sage Therap(SAGE.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Jul31
Sage Therap released FY2025 Q2 earnings on July 30 (EST), actual revenue USD 31.66 M (forecast USD 16.73 M), actual EPS USD -0.793 (forecast USD -0.9521)
03:00
Jul11
Halper Sadeh Investigating Fairness of Proposed Sage Therapeutics Acquisition
11:51
Jul1
Sage Therapeutics Acquired by Supernus Pharmaceuticals and Laying Off Staff
14:48
Jun17
Truist Financial Raises Sage Therapeutics Target Price to $9
14:58
Halper Sadeh LLC Investigates Sage Therapeutics
01:23
Jun4
Merrill Lynch Cut Its Holdings in Sage Therapeutics
07:04

Schedules & Filings

Schedules
Filings
Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 31.66 M, Net Income -49.65 M, EPS -0.793

Apr29
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.06 M, Net Income -62.21 M, EPS -1.0057

Feb11
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 12.82 M, Net Income -95.78 M, EPS -1.5633

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
9.530
+132.44%
+5.430
ANGH
3.770
+62.50%
+1.450
WTO
1.020
+61.09%
+0.387
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2731
+40.77%
+0.079
FGMCR
0.5500
+33.50%
+0.138
ESHA
19.180
+33.38%
+4.800
IPEXR
0.8000
+31.97%
+0.194
RDACR
0.2400
+26.32%
+0.050
DVLT
0.6521
+26.25%
+0.136
View More